ES2542156A1 - Gel frío de Aloe Vera natural sin estabilizadores - Google Patents

Gel frío de Aloe Vera natural sin estabilizadores Download PDF

Info

Publication number
ES2542156A1
ES2542156A1 ES201430109A ES201430109A ES2542156A1 ES 2542156 A1 ES2542156 A1 ES 2542156A1 ES 201430109 A ES201430109 A ES 201430109A ES 201430109 A ES201430109 A ES 201430109A ES 2542156 A1 ES2542156 A1 ES 2542156A1
Authority
ES
Spain
Prior art keywords
aloe vera
translation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201430109A
Other languages
English (en)
Other versions
ES2542156B1 (es
Inventor
Maria Del Mar TELLO DE JUAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES201430109A priority Critical patent/ES2542156B1/es
Priority to PCT/ES2014/070986 priority patent/WO2015114181A1/es
Priority to US15/037,577 priority patent/US20160375081A1/en
Priority to EP14880930.4A priority patent/EP3067060A4/en
Priority to CN201480065835.3A priority patent/CN105873597A/zh
Publication of ES2542156A1 publication Critical patent/ES2542156A1/es
Application granted granted Critical
Publication of ES2542156B1 publication Critical patent/ES2542156B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención, se refiere a un procedimiento en base al cual es posible hacer uso de un gel puro de aloe vera que contiene todas las propiedades naturales de la planta basándose en la incorporación de un proceso de estabilización por congelación, en base al cual es posible su administración en frío por vía tópica en forma de crema, loción, pomada o ungüento con los uso habituales del Aloe Vera aunque fundamentalmente para aliviar quemaduras de cualquier tipo.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
P201430109
30-01-2014
imagen8
El uso del gel de Aloe vera descrito en este documento se ilustra mediante los siguientes ejemplos.
5 Ejemplo 1 Es conocido por las personas que se dedican a oficios donde existen riesgos para los ojos por quemadura ocasionales de la conjuntiva por chispas, tales como soldadores, las molestias que estas quemaduras pueden llegar a provocar. La gelatina clara
10 proveniente de las hojas frescas de Aloe vera es estéril y calmante. Así, en una o dos instilaciones directas en el ojo o los ojos afectados se alivia rápidamente todos los síntomas y acelera el proceso de curación. De hecho, la conjuntivitis puede tener una forma aguda o crónica, siendo el Aloe Vera apropiado en
15 ambos casos tanto en forma de gotas como de gelatina.
Así haciendo uso del Gel frío de Aloe Vera natural sin estabilizadores en estas aplicaciones no sería necesario realizar el corte de una hoja de la planta, desperdiciando de esta manera
20 una hoja entera mientras que lo que se requiere solamente son unas gotas de gel al día para la conjuntivitis o para cualquier otra aplicación cosmética o terapéutica de aplicación diaria. Con la presente invención, simplemente descongelando en este caso una monodosis de 1,5 ml se obtendría gel suficiente para un
25 tratamiento diario.
P201430109
30-01-2014
Ejemplo 2 Una mujer de 55 años, que accidentalmente en la cocina, se le derramó un cazo de sopa hirviendo en las piernas y pies, sufriendo quemaduras de tercer grado. Gracias a la pronta
5 reacción de su hija que tras escuchar sus gritos le echó por encima de las piernas jarros de agua fría y, seguidamente, colocándole gelatinas congeladas de hojas de aloe vera a modo de compresas, aliviando su dolor hasta que las gelatinas se descongelaban y se quedaban sin gel, después de una semana
10 de tratamiento a base de gelatina y gel congelado de aloe vera, se le curaron las quemaduras sin dejar cicatrices.
Así haciendo uso del Gel frío de Aloe Vera natural sin estabilizadores que se puede conservar en cualquier casa
15 congelado en dosis adecuadas se alivia el calor que se acumula en la piel al sufrir una quemadura de cualquier tipo, enfriando rápidamente la piel quemada, mientras que el gel congelado neutraliza el dolor a la vez que se derrite y es absorbido por la piel quemada.
20 Los resultados clínicos precedentes indican claramente que el gel de Aloe vera objeto de la presente invención demostró ser útil en las aplicaciones descritas.

Claims (1)

  1. imagen1
    imagen2
ES201430109A 2014-01-30 2014-01-30 Gel frío de Aloe Vera natural sin estabilizadores Active ES2542156B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES201430109A ES2542156B1 (es) 2014-01-30 2014-01-30 Gel frío de Aloe Vera natural sin estabilizadores
PCT/ES2014/070986 WO2015114181A1 (es) 2014-01-30 2014-12-29 Gel frío de aloe vera natural sin estabilizadores
US15/037,577 US20160375081A1 (en) 2014-01-30 2014-12-29 Cold natural aloe vera gel without stabilisers
EP14880930.4A EP3067060A4 (en) 2014-01-30 2014-12-29 Cold natural aloe vera gel without stabilisers
CN201480065835.3A CN105873597A (zh) 2014-01-30 2014-12-29 不含稳定剂的天然芦荟冷凝胶

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430109A ES2542156B1 (es) 2014-01-30 2014-01-30 Gel frío de Aloe Vera natural sin estabilizadores

Publications (2)

Publication Number Publication Date
ES2542156A1 true ES2542156A1 (es) 2015-07-31
ES2542156B1 ES2542156B1 (es) 2016-05-13

Family

ID=53718204

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201430109A Active ES2542156B1 (es) 2014-01-30 2014-01-30 Gel frío de Aloe Vera natural sin estabilizadores

Country Status (5)

Country Link
US (1) US20160375081A1 (es)
EP (1) EP3067060A4 (es)
CN (1) CN105873597A (es)
ES (1) ES2542156B1 (es)
WO (1) WO2015114181A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106360718A (zh) * 2016-08-26 2017-02-01 湖州佳美生物化学制品有限公司 一种芦荟凝胶的提取工艺
CN107693662A (zh) * 2017-10-18 2018-02-16 南昌大学 一种益生菌芦荟液及其用于制备烧伤创面药物用途
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法
US20220280587A1 (en) * 2021-03-03 2022-09-08 Mark Edward Fenzl Medical gels containing a quaternary ammonium compound, phenoxyethanol, aloe vera juice, and natural sporicidal moisturizers
EP4230187A1 (en) 2022-02-21 2023-08-23 Biofactoria Naturae Et Salus Sa Single-dose cosmetic product and process of manufacturing thereof
WO2023175629A1 (en) * 2022-03-15 2023-09-21 Yushuna Healthcare Pvt. Ltd. Topical herbal cream composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES370276A1 (es) * 1969-08-06 1971-04-01 Rogers Marsh Jr Gel de aloe en forma cristalina y metodo para fabricarlo y reconstruirlo.
US3892853A (en) * 1967-05-22 1975-07-01 Aloe 99 & 0 Inc Stabilized aloe vera gel and preparation of same
ES8801986A1 (es) * 1985-06-28 1988-03-16 Carrington Lab Inc Un procedimiento para producir un gel o jugo de aloe sustancialmente exento de antraquinona.
US5356811A (en) * 1992-04-21 1994-10-18 Coats Billy C Method of processing stabilized aloe vera gel obtained from the whole aloe vera leaf
US6013259A (en) * 1997-09-22 2000-01-11 De De La Pena; Nuria E. A. C. Patent on use of aloe vera ophthalmic solution for treatment of the dry eye syndrome, inflammations, ulcerations, alkaline or acid burns, infections, and cataracts
US20060134238A1 (en) * 2004-12-16 2006-06-22 Dnyaneshwar Agashe M Process of manufacturing clear juice from the leaves of the aloe vera plant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653333B1 (fr) 1989-10-23 1992-02-07 Isnard Camille Produit a base de jus de feuilles d'aloes, procede de preparation et application.
AU2196195A (en) 1994-03-28 1995-10-17 Skin Biology, Inc. Metal complexes of aloe extracts for skin and hair
ES2123465B1 (es) 1997-06-03 1999-08-16 Perez Rivera Angela Una composicion dermatologica regeneradora del cabello y para el tratamiento de la piel.
CN1121233C (zh) * 1998-12-07 2003-09-17 成都赛维芦荟制品有限公司 芦荟凝胶粉的制备方法
DE10032109A1 (de) * 2000-07-01 2002-03-28 Bernd Blaudszun Verfahren und Anlage zur Gewinnung von biowirksamen Bestandteilen der Aloe vera
ES2232303B1 (es) 2003-11-07 2006-03-16 Rafael Martinez Hernandez Composicion de una crema cosmetica y/o terapeutica.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892853A (en) * 1967-05-22 1975-07-01 Aloe 99 & 0 Inc Stabilized aloe vera gel and preparation of same
ES370276A1 (es) * 1969-08-06 1971-04-01 Rogers Marsh Jr Gel de aloe en forma cristalina y metodo para fabricarlo y reconstruirlo.
ES8801986A1 (es) * 1985-06-28 1988-03-16 Carrington Lab Inc Un procedimiento para producir un gel o jugo de aloe sustancialmente exento de antraquinona.
US5356811A (en) * 1992-04-21 1994-10-18 Coats Billy C Method of processing stabilized aloe vera gel obtained from the whole aloe vera leaf
US6013259A (en) * 1997-09-22 2000-01-11 De De La Pena; Nuria E. A. C. Patent on use of aloe vera ophthalmic solution for treatment of the dry eye syndrome, inflammations, ulcerations, alkaline or acid burns, infections, and cataracts
US20060134238A1 (en) * 2004-12-16 2006-06-22 Dnyaneshwar Agashe M Process of manufacturing clear juice from the leaves of the aloe vera plant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RAMACHANDRA, C. T. & RAO, P. S. Processing of Aloe Vera Leaf Gel: A Review. American Journal of Agricultural and Biological Sciences, 2008; Vol. 3, nº 2, páginas 502-510. *

Also Published As

Publication number Publication date
US20160375081A1 (en) 2016-12-29
CN105873597A (zh) 2016-08-17
ES2542156B1 (es) 2016-05-13
EP3067060A1 (en) 2016-09-14
EP3067060A4 (en) 2017-06-28
WO2015114181A1 (es) 2015-08-06

Similar Documents

Publication Publication Date Title
ES2542156A1 (es) Gel frío de Aloe Vera natural sin estabilizadores
BR112015010477A2 (pt) combinação farmacêutica que compreende um inibidor b-raf e um inibidor de histona desacetilase e o uso dos mesmos no tratamento de doenças proliferativas
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
MX2016011975A (es) Metodos para reducir el riesgo cardiovascular.
WO2016090024A3 (en) Combination therapy for treatment of cancer
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
RU2017120184A (ru) Лекарства для замедления течения болезни паркинсона
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
EA201691555A1 (ru) Способы лечения и предотвращения заболеваний почек и жировых дистрофий печени
ES2540151A1 (es) Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
MX2021002017A (es) Uso de roluperidona para tratar sintomas y trastornos negativos, aumentar la neuroplasticidad y promover la neuroproteccion.
PH12018501790A1 (en) Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapy
EA201591603A1 (ru) Новые терапевтические комбинации миртазапина для применения при болевых расстройствах
Halim et al. Comparison of the effectiveness between virgin coconut oil (VCO) and triamcinolone for treatment of minor recurrent aphthous stomatitis (RAS)
WO2019118779A3 (en) Peptides and other agents for treating pain and increasing pain sensitivity
BR112015009504A2 (pt) inibidores de rock
BR112015007095A8 (pt) derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados, composição farmacêutica compreendendoos e uso dos referidos derivados
EA201291442A1 (ru) Комбинированная терапия с криохирургией и имиквимодом с низкой дозировкой для лечения актинического кератоза
PE20181329A1 (es) Metodos y composiciones para el tratamiento del sindrome de hunter
WO2015166418A3 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
RU2688182C2 (ru) Охлаждающе-согревающий пластырь
Mashi Effect of green tea extract on injured liver induced by Acetaaminophen in rabbits adult male
Hota et al. Management of cold injuries
ES2692845T3 (es) Composición para aliviar el dolor, el estrés y el insomnio
CN104984088A (zh) 一种治疗外伤感染的中药药方

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2542156

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20160513